Nashville Biosciences leverages Vanderbilt University Medical Center’s massive, de-identified biobank (BioVU®) to provide life science companies with deep genomic and real-world clinical data. By linking millions of longitudinal electronic health records to genetic data, Nashville Biosciences accelerates drug discovery, target validation, and clinical trial optimization for precision medicine.
Subscribe to our newsletter
Subscribe to receive the latest news and innovations straight to your inbox.
Your subscription could not be saved. Please try again.
We use cookies for various purposes including to make your experience of our website better. Please confirm below that you consent to our use of non-essential cookies in accordance with our cookies policy. Click here to access our cookies policy and find out more about our cookie use and how to disable cookies.